Sign in

Luke Lambourne

@lukelambourne.bsky.social
57 followers 131 following 14 posts

Scientist at Dana-Farber Cancer Institute / Harvard Medical School

PostsRepliesMedia
Reposted by Luke Lambourne
Pedro Beltrao @pedrobeltrao.bsky.social · 03/09/2026
8.8% success rate for the ERC Starting Grant is not acceptable. It is a lottery at this point with so many great scientists and ideas left to be funded. We keep talking about the competitiveness of Europe and we can't agree to properly fund our best instrument for scientific innovation.
37722
Reposted by Luke Lambourne
Fritz Roth @fritzroth.bsky.social · 06/08/2026
🧪 One small step towards a complete atlas of human sequence variant effects, a giant leap for figuring out which variants in the Autoimmune Regulator (AIRE) protein are pathogenic, and some baby steps towards understanding the AIRE protein @varianteffect.bsky.social
0135
Reposted by Luke Lambourne
Katja Luck @katjaluck.bsky.social · 31/07/2026
Check out our new article if you are interested in disorder-mediated protein interactions, AlphaFold-based structural modeling and variant characterization: rdcu.be/fw2oz Dx.doi.org/10.1038/s41594-026-01846-z
dx.doi.org
Variant characterization in the intrinsically disordered human proteome - Nature Structural & Molecular Biology
Proteome-wide prediction and structural modeling of disordered protein interaction interfaces advance characterization of disease-associated variants in disordered protein regions.
23614
Luke Lambourne @lukelambourne.bsky.social · 03/06/2026
Excited that the final version of our experimental assessment of AI protein interaction predictions is out: www.nature.com/articles/s41... Brief summary below:
nature.com
Experimental assessment of AI-based interactome mapping - Nature Communications
AlphaFold’s success in protein structure predictions has led to similar attempts to predict interactomes. Here, the authors demonstrate that AI-based screens are very limited in discovering truly nove...
144
Reposted by Luke Lambourne
Simon Kozlov @sim0nsays.bsky.social · 01/05/2026
Yours truly is a proper scientist now! TL;DR: we used AI to redesign parts of essential cell machinery with only 19 canonical amino acids instead of 20. Why? Great thread by @harriswang.bsky.social provides more context and details. Let me talk a bit about the AI design part of this. 1/
1184
Reposted by Luke Lambourne
Joe Marsh @jmarshlab.bsky.social · 24/04/2026
New work led by Hasan Cubuk: moving from interpreting variants individually to combining both alleles in recessive disease. DMS of >8000 ADSL variants → inferred enzyme activity → additive biallelic scores that track patient phenotypes. Great collab with the Kudla lab! www.cell.com/cell-systems...
cell.com
Mechanistic modeling of recessive disease through allelic integration of variant effects
Recessive diseases arise from the combined effects of two alleles, yet most variant interpretation methods consider variants individually. Çubuk et al. map more than 8,000 variants in the recessive en...
0113
Reposted by Luke Lambourne
Nature Microbiology @natmicrobiol.nature.com · 26/01/2026
Out Now! Effector–host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation #MicroSky
go.nature.com
Effector–host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation
Nature Microbiology, Published online: 26 January 2026; doi:10.1038/s41564-025-02241-yLarge-scale computational and in vitro analyses identify commensal type III secretion systems and substrates in the human gut microbiome that can interact with human proteins to modulate immune pathways.
0157
Reposted by Luke Lambourne
Pascal Falter-Braun @interactome.bsky.social · 26/01/2026
Very happy and proud that our paper “Effector–host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation” is out today in #NatureMicrobiology @natmicrobiol.nature.com Paper 👉 t1p.de/v42xb #microbiome #commensal #pathomechanism #T3SS #immune #health #IBD
t1p.de
Effector–host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation - Nature Microbiology
Large-scale computational and in vitro analyses identify commensal type III secretion systems and substrates in the human gut microbiome that can interact with human proteins to modulate immune pathwa...
12511
Reposted by Luke Lambourne
Kaia Mattioli @kaiamattioli.bsky.social · 11/12/2025
delighted to share our review, out today in @cp-trendsgenetics.bsky.social! check it out if you're curious about how recent advances in technology & biology have contributed to our understanding of how alternative isoforms diversify the proteome.
175
Reposted by Luke Lambourne
Alexandra Bendel @alexbendel.bsky.social · 25/08/2025
I am happy to finally share this preprint of my PhD project in @guillaumediss.bsky.social lab at the FMI in Basel. We used ddPCA to map the genetic architecture of the entire human bZIP interaction network. www.biorxiv.org/content/10.1... Thanks to all our co-authors for the great collaboration!
biorxiv.org
The genetic architecture of the human bZIP family
Generative biology holds the promise to transform our ability to design and understand living systems by creating novel proteins, pathways, and organisms with tailored functions that address challenge...
13213
Reposted by Luke Lambourne
Juan Fuxman Bass @fuxmanlab.bsky.social · 08/08/2025
Excited to share this collaborative review with @dsegre.bsky.social and @devmoy.bsky.social. We discuss common issues with context-specific genome-scale metabolic network models and provide recommendation for future model development.
052
Reposted by Luke Lambourne
Juan Fuxman Bass @fuxmanlab.bsky.social · 24/07/2025
Exited to share our recent work on viral cis-regulatory elements in collaboration with @tewhey.bsky.social! We identified >2000 CREs across the genomes of 27 human-infecting dsDNA viruses from the Herpesvirus, Adenovirus, Papillomavirus, and Polyomavirus families. www.biorxiv.org/content/10.1... 1/8
173
Reposted by Luke Lambourne
Katja Luck @katjaluck.bsky.social · 01/07/2025
Variant characterization in the intrinsically disordered human proteome - here is how we did it using short linear motif prediction, AlphaFold, and experimentation. Check out our preprint: www.biorxiv.org/cgi/content/...
biorxiv.org
Variant characterization in the intrinsically disordered human proteome
Variant effect prediction remains a key challenge to resolve in precision medicine. Sophisticated computational models that exploit sequence conservation and structure are increasingly successful in t...
02211
Reposted by Luke Lambourne
Mike Murphy @mitoredox.bsky.social · 29/05/2025
Congrats to Renata Goncalves who led a study in Gokhan Hotamisligil's lab that has just come out in Nature - ably assisted by Jillian Riveros! www.nature.com/articles/s41...
nature.com
CoQ imbalance drives reverse electron transport to disrupt liver metabolism - Nature
Reverse electron transport is the mechanism behind excess mitochondrial reactive oxygen species in the livers of obese mice, which has implications for developing therapeutics for fatty liver dis...
184
Reposted by Luke Lambourne
Molecular Cell @cp-molcell.bsky.social · 08/04/2025
Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms
dlvr.it
Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms
Lambourne, Mattioli, Santoso, et al. compare protein isoforms of the same transcription factor genes through high-throughput profiling of DNA-binding, protein-binding, activation, localization, and condensate formation. Differences between isoforms are widespread, often unpredictable from sequence differences, and inform a disease-associated categorization of alternative isoforms into rewirers or negative regulators.
042
Reposted by Luke Lambourne
Molecular Cell @cp-molcell.bsky.social · 27/03/2025
Online Now: Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms Online now:
dlvr.it
Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms
Lambourne, Mattioli, Santoso, et al. compare protein isoforms of the same transcription factor genes through high-throughput profiling of DNA-binding, protein-binding, activation, localization, and condensate formation. Differences between isoforms are widespread, often unpredictable from sequence differences, and inform a disease-associated categorization of alternative isoforms into rewirers or negative regulators.
042
Reposted by Luke Lambourne
Kaia Mattioli @kaiamattioli.bsky.social · 26/03/2025
reposting the 🧵 from the other site that I wrote when the preprint came out: TFs, like most genes, are frequently expressed as a series of multiple distinct isoforms. these isoforms (by definition) differ in sequence -- often in annotated protein domain regions (e.g. DNA-binding & effector domains)
121
Luke Lambourne @lukelambourne.bsky.social · 26/03/2025
The published version of our transcription factor isoforms survey is online www.sciencedirect.com/science/arti... we cloned 100's of isoforms (that arise through alternative splicing etc.) testing them in high-throughput assays for DNA-binding, protein-binding, activation, and more.
2164
Reposted by Luke Lambourne
Kaia Mattioli @kaiamattioli.bsky.social · 26/03/2025
our work on the molecular differences between transcription factor isoforms is out now in Molecular Cell! key point: 2/3rds of TF isos differ in properties like DNA binding & transcriptional activity many are "negative regulators" & misexpressed in cancer www.sciencedirect.com/science/arti...
716070
Reposted by Luke Lambourne
𝙲𝚑𝚊𝚛𝚕𝚎𝚜 𝙲. 𝙼𝚊𝚗𝚗 @charlescmann.bsky.social · 26/02/2025
As the first measles death in the US since 2015--an unvaccinated child--is reported, let us read the thoughts of our new Secretary of Health and Human Services on this disease. www.reuters.com/world/us/fir... (Foreword to "The Measles Book", 2021)
Foreword to "The Measles Book", written by RFK, Jr. promises that "readers--Americans and global consumers of measles vaccines--will learn that they have been misled by the pharmaceutical industry and their captured government agency allies into believing that measles is a deadly disease and that measles vaccines are necessary, safe, and effective."
27342
Reposted by Luke Lambourne
Carl Zimmer @carlzimmer.com · 19/02/2025
On Wednesday 2/26, I’ll be in Boston to give a Harvard Science Book Talk. I’ll have a marvelous relic of aerobiological history to unveil. Details here: www.harvard.com/event/carl-z... 3/5
harvard.com
212
Reposted by Luke Lambourne
Alex Holehouse @alexholehouse.bsky.social · 15/02/2025
The STARLING has landed - excited to share new work from @bornanovak.bsky.social and @jefflotthammer.bsky.social in what is also Borna's first Bluesky post! If you're at BPS, I'll be speaking about this this afternoon in IDP SG, and Borna and Jeff both have posters (Sunday B112 and Wed B152).
04114
Reposted by Luke Lambourne
Katja Luck @katjaluck.bsky.social · 14/02/2025
Interested in learning about biases in protein-protein interface predictions with AlphaFold2? Check out our new review on this topic: authors.elsevier.com/a/1kbSa_,2Bd...
authors.elsevier.com
0123
Reposted by Luke Lambourne
Pascal Falter-Braun @interactome.bsky.social · 14/01/2025
Btw, the abstract deadline has been extended to Jan 27!
012
Reposted by Luke Lambourne
Fritz Roth @fritzroth.bsky.social · 14/01/2025
🧪 If you are a network (or network-curious!) biologist, please consider attending the upcoming CSHL Network Biology Meeting. Details + abstract deadline below!
084
Reposted by Luke Lambourne
Ben Lehner @benlehner.bsky.social · 03/12/2024
Can a single small molecule rescue the stability of nearly all mutations in a protein? Our new preprint by Taylor Mighell www.biorxiv.org/content/10.1... thread on the other place: x.com/taylor_mighe...
biorxiv.org
A pharmacological chaperone stabilizer rescues the expression of the vast majority of pathogenic variants in a G protein-coupled receptor
Reduced protein stability is the most frequent mechanism by which rare missense variants cause disease. A promising therapeutic avenue for treating destabilizing variants is pharmacological chaperones...
36824